Authors: O'Brien, PM Ortwine, DF Pavlovsky, AG Picard, JA Sliskovic, DR Roth, BD Dyer, RD Johnson, LL Man, C Hallak, H

Citation: Pm. O'Brien et al., Structure-activity relationships and pharmacokinetic analysis for a seriesof potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors, J MED CHEM, 43(2), 2000, pp. 156-166

Authors: Johnson, LL Pavlovsky, AG Johnson, AR Janowicz, JA Man, CF Ortwine, DF Purchase, CF White, AD Hupe, DJ

Citation: Ll. Johnson et al., A rationalization of the acidic pH dependence for stromelysin-1 (matrix metalloproteinase-3) catalysis and inhibition, J BIOL CHEM, 275(15), 2000, pp. 11026-11033

Authors: Pavlovsky, AG Williams, MG Ye, QZ Ortwine, DF Purchase, CF White, AD Dhanaraj, V Roth, BD Johnson, LL Hupe, D Humblet, C Blundell, TL

Citation: Ag. Pavlovsky et al., X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity, PROTEIN SCI, 8(7), 1999, pp. 1455-1462

Authors: Johnson, LL Bornemeier, DA Janowicz, JA Chen, J Pavlovsky, AG Ortwine, DF

Citation: Ll. Johnson et al., Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency -An explanation of inhibitor selectivity using homology modeling and chimeric proteins, J BIOL CHEM, 274(35), 1999, pp. 24881-24887

Authors: Parker, MH Lunney, EA Ortwine, DF Pavlovsky, AG Humblet, C Brouillette, CG

Citation: Mh. Parker et al., Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry, BIOCHEM, 38(41), 1999, pp. 13592-13601